FDA Approves At-Home Device for Treatment-Resistant Depression

(MedPage Today) — The FDA approved a prescription at-home brain neuromodulation therapy as an adjunctive depression treatment for adults, maker Neurolief announced on Tuesday.
ProlivRx is the first home-based prescription device to deliver focal…

Source link : https://www.medpagetoday.com/psychiatry/depression/119430

Author :

Publish date : 2026-01-14 20:28:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

FDA Approves At-Home Device for Treatment-Resistant Depression

U.S. Overdose Deaths Fell Through Most of 2025, Federal Data Reveal

GLP-1 Drugs Tied to Mortality Reduction in Colon Cancer Patients With Obesity

Related Posts

GLP-1 Drugs Tied to Mortality Reduction in Colon Cancer Patients With Obesity

U.S. Overdose Deaths Fell Through Most of 2025, Federal Data Reveal

What’s in a Name? A New One Might Help PCOS Patients

Cardiovascular Risk Score Shows Value in Predicting Future Eye Disease

FDA Requests Removal of Suicide Warning on GLP-1s

Flu Antiviral Use Among Hospitalized Kids Fell During COVID Pandemic

GLP-1 Drugs Tied to Mortality Reduction in Colon Cancer Patients With Obesity

FDA Approves At-Home Device for Treatment-Resistant Depression

U.S. Overdose Deaths Fell Through Most of 2025, Federal Data Reveal

What’s in a Name? A New One Might Help PCOS Patients

Cardiovascular Risk Score Shows Value in Predicting Future Eye Disease

FDA Requests Removal of Suicide Warning on GLP-1s

Flu Antiviral Use Among Hospitalized Kids Fell During COVID Pandemic

Cheap Surgery Abroad Leaves NHS With Big Bills

Categories

Archives